Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-11-30 17:26:24
Reporting Period:
Accepted Time:
2018-11-30 17:26:24
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1429260 Fortress Biotech Inc. FBIO Pharmaceutical Preparations (2834) 205157386
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713932 Robyn Hunter C/o Fortress Biotech, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-11-23 20,370 $1.29 239,759 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. In connection with the vesting of 62,500 shares on November 20, 2018, a total of 20,370 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
  2. Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 23, 2018, was $1.28 to $1.34. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Of the 239,759 shares, 187,500 shares are restricted stock units.